Literature DB >> 35831060

VIBe Scale: Validation of the Intraoperative Bleeding Severity Scale by Spine Surgeons.

Daniel M Sciubba1,2, Nitin Khanna3, Zach Pennington4,5, Rahul K Singh6.   

Abstract

BACKGROUND: The Validated Intraoperative Bleeding Scale (VIBe Scale) was initially validated with surgeons who operate on cardiothoracic, abdominal, and pelvic cavities and fulfilled criteria for a clinician-reported scale. However, there is a need for a tool to aid in intraoperative blood management during spine surgeries. The purpose of the present study was to establish the reliability and consistency of the VIBe Scale as a tool for spine surgeons to assess intraoperative bleeding.
METHODS: Orthopedic (n = 16) and neurological (n = 9) spine surgeons scored videos depicting surgical bleeding and assessed the VIBe Scale's relevance and clarity. Inter- and intraobserver agreement (Kendall's W) were calculated for all surgeons and pooled with responses from the original study to establish agreement across specialties.
RESULTS: All of the spine surgeons indicated that the scale was clinically relevant for evaluating hemostasis and could be implemented in a clinical study. Twenty-two spine surgeons (88%) reported that the scale represents the range of bleeding site sizes and severities expected in their practice. Twenty-four spine surgeons (96%) indicated that the scale would be useful in communicating bleeding severity with other members of the surgical team. Interobserver agreement was acceptable (0.79) for orthopedic specialists, appreciable (0.88) for neurological specialists, and appreciable (0.88) for the combined specialists. Intraobserver agreement was excellent for orthopedic (0.91) and neurological (0.91) spine surgeons and excellent (0.96) for the combined specialists.
CONCLUSIONS: The results highlight the reliability of the VIBe Scale and potential utility for quantifying intraoperative blood loss in spine surgery. CLINICAL RELEVANCE: The VIBe Scale may be useful for evaluating the efficacy of untested intraoperative hemostatic agents and for comparing the relative efficacy of 2 or more analogous agents. It may also prove useful for intraoperative staff by quantifying ongoing intraoperative blood loss and correlating losses with the potential transfusion and intraoperative hemostatic agent requirements. This manuscript is generously published free of charge by ISASS, the International Society for the Advancement of Spine Surgery.
Copyright © 2022 ISASS. To see more or order reprints or permissions, see http://ijssurgery.com.

Entities:  

Keywords:  VIBe; bleeding; hemostasis; scale; spine; surgery; validation

Year:  2022        PMID: 35831060      PMCID: PMC9421269          DOI: 10.14444/8304

Source DB:  PubMed          Journal:  Int J Spine Surg        ISSN: 2211-4599


  31 in total

1.  Proceedings From the Society for Advancement of Blood Management Annual Meeting 2017: Management Dilemmas of the Surgical Patient-When Blood Is Not an Option.

Authors:  Gee Mei Tan; Nicole R Guinn; Steven M Frank; Aryeh Shander
Journal:  Anesth Analg       Date:  2019-01       Impact factor: 5.108

2.  Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents.

Authors:  Kevin M Lewis; Qing Li; Drew S Jones; JoMichelle D Corrales; Hongyan Du; Philippe E Spiess; Emanuele Lo Menzo; Abe DeAnda
Journal:  Surgery       Date:  2016-11-10       Impact factor: 3.982

3.  Reduction of Mean Arterial Pressure at Incision Reduces Operative Blood Loss in Adolescent Idiopathic Scoliosis.

Authors:  Kushagra Verma; Baron Lonner; Laura Dean; David Vecchione; Virginie Lafage
Journal:  Spine Deform       Date:  2013-03-15

4.  Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery.

Authors:  Laurent G Glance; Andrew W Dick; Dana B Mukamel; Fergal J Fleming; Raymond A Zollo; Richard Wissler; Rabih Salloum; U Wayne Meredith; Turner M Osler
Journal:  Anesthesiology       Date:  2011-02       Impact factor: 7.892

5.  Implementation of a specific safety check is associated with lower postoperative mortality in cardiac surgery.

Authors:  Alexander J Spanjersberg; Jan Paul Ottervanger; Arno P Nierich; Ron G H Speekenbrink; Wim Stooker; Marga Hoogendoorn; Dennis van Veghel; Saskia Houterman; George J Brandon Bravo Bruinsma
Journal:  J Thorac Cardiovasc Surg       Date:  2019-08-28       Impact factor: 5.209

6.  Effect of a comprehensive surgical safety system on patient outcomes.

Authors:  Eefje N de Vries; Hubert A Prins; Rogier M P H Crolla; Adriaan J den Outer; George van Andel; Sven H van Helden; Wolfgang S Schlack; M Agnès van Putten; Dirk J Gouma; Marcel G W Dijkgraaf; Susanne M Smorenburg; Marja A Boermeester
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

7.  Blood Transfusion and Postoperative Infection in Spine Surgery: A Systematic Review.

Authors:  Christian Fisahn; Cameron Schmidt; Josh E Schroeder; Emiliano Vialle; Isador H Lieberman; Joseph R Dettori; Thomas A Schildhauer
Journal:  Global Spine J       Date:  2018-02-09

8.  SPOT GRADE II: Clinical Validation of a New Method for Reproducibly Quantifying Surgical Wound Bleeding: Prospective, Multicenter, Multispecialty, Single-Arm Study.

Authors:  Daniel J Del Gaizo; William D Spotnitz; Rachel W Hoffman; Mark Christopher Hermann; Linda S Sher; Russell H Spotnitz; Yuri S Genyk; Ian J Schorn; Daniel L Gillen; Bobby L White; Bruce G Miller; Roberto J Manson
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

9.  Comparison the efficacy of hemorrhage control of Surgiflo Haemostatic Matrix and absorbable gelatin sponge in posterior lumbar surgery: A randomized controlled study.

Authors:  Litai Ma; Lijuan Dai; Yi Yang; Hao Liu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

10.  Is blood transfusion associated with an increased risk of infection among spine surgery patients?: A meta-analysis.

Authors:  Yu-Kun He; Hui-Zi Li; Hua-Ding Lu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.